Preliminary experiments indicate conolidine might inhibit distinct ion channels, minimizing neuronal excitability and restricting ache alerts. This system is particularly pertinent in neuropathic pain, exactly where abnormal signaling triggers persistent soreness. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathways